9 Kidney Cancer Clinical Trials in Duarte, CA (2026)

Q: How do I join a clinical trial in Duarte?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you.

Recruiting Kidney Cancer Studies in Duarte

NCT06661720Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immun...

Duarte, CAPHASE31,040 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT07011719Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

The purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is given in combination with cabozantinib in adult patients with confirmed advanced o...

Duarte, CAPHASE3720 participantsArcus Biosciences, Inc.

View Study Details

NCT05433142Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinom...

Duarte, CAPHASE1307 participantsXencor, Inc.

View Study Details

NCT05327686Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherap...

Duarte, CAPHASE2240 participantsNRG Oncology

View Study Details

NCT05361720Recruiting

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

This phase II trial tests whether using genetic testing of tumor tissue to select the optimal treatment regimen works in treating patients with clear cell renal cell (kidney) cancer that has spread to...

Duarte, CAPHASE254 participantsVanderbilt-Ingram Cancer Center

View Study Details

NCT07128680Recruiting

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

This phase I trial tests the safety and effectiveness of nivolumab and ipilimumab with and without EXL01 for the treatment of renal cell cancer that has spread from where it first started (primary sit...

Duarte, CAPHASE133 participantsCity of Hope Medical Center

View Study Details

NCT07226544Recruiting

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

This phase II trial studies how well ivonescimab works prior to surgery in treating patients with high-risk clear cell kidney (renal cell) cancer that has not spread to other parts of the body (locali...

Duarte, CAPHASE231 participantsCity of Hope Medical Center

View Study Details

NCT07300241Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

The NEO-811-101 study is an open-label, first-in-human, Phase 1/2 dose escalation and expansion study testing NEO-811, an ARNT molecular glue degrader, in subjects with locally advanced or metastatic ...

Duarte, CAPHASE130 participantsNeomorph, Inc

View Study Details

NCT06399419Recruiting

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

This phase I trial tests the safety, side effects, best dose, and effectiveness of CBM588 in combination with nivolumab and ipilimumab in treating patients with kidney cancer that may have spread from...

Duarte, CAPHASE128 participantsOsel, Inc.

View Study Details

About Kidney Cancer Clinical Trials in Duarte

Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.

There are currently 9 kidney cancer clinical trials recruiting participants in Duarte, CA. These studies are seeking a combined 2,483 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, Arcus Biosciences, Inc., Xencor, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Kidney Cancer Clinical Trials in Duarte — FAQ

Are there kidney cancer clinical trials in Duarte?

Yes, there are 9 kidney cancer clinical trials currently recruiting in Duarte, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What kidney cancer treatments are being tested?

The 9 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.

Data updated July 18, 2026 from ClinicalTrials.gov